Cytotoxic sulphonamides designed for selective deposition in malignant tissue.
D000818:Animals; D004305:Dose-Response Relationship, Drug; D006207:Half-Life; D006863:Hydrogen-Ion Concentration; D008099:Liver / Q000378:metabolism; D008223:Lymphoma / Q000188:drug therapy / Q000378:metabolism; D051379:Mice; D009374:Neoplasms, Experimental / Q000378:metabolism; D010954:Plasmacytoma / Q000188:drug therapy* / Q000378:metabolism; D013449:Sulfonamides / Q000378:metabolism / Q000627:therapeutic use*; D014226:Triazenes / Q000008:administration & dosage / Q000627:therapeutic use; D014227:Triazines / Q000378:metabolism
D013449:Sulfonamides; D014226:Triazenes; D014227:Triazines